IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v16y2019i4p605-d207248.html
   My bibliography  Save this article

Essential Medicines at the National Level: The Global Asthma Network’s Essential Asthma Medicines Survey 2014

Author

Listed:
  • Karen Bissell

    (School of Population Health, University of Auckland, Auckland 1023, New Zealand)

  • Philippa Ellwood

    (Department of Paediatrics: Child and Youth Health, University of Auckland, Auckland 1023, New Zealand)

  • Eamon Ellwood

    (Department of Paediatrics: Child and Youth Health, University of Auckland, Auckland 1023, New Zealand)

  • Chen-Yuan Chiang

    (Division of Pulmonary Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 116, Taiwan
    Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan)

  • Guy B. Marks

    (South Western Sydney Clinical School, University of New South Wales, Sydney 2085, Australia)

  • Asma El Sony

    (The Epidemiological Laboratory (Epi-Lab), for Public Health and Research, Khartoum, Sudan)

  • Innes Asher

    (Department of Paediatrics: Child and Youth Health, University of Auckland, Auckland 1023, New Zealand)

  • Nils Billo

    (Independent Consultant, 80220 Joensuu, Finland)

  • Christophe Perrin

    (Farmalex, 75008 Paris, France)

  • the Global Asthma Network Study Group

    (Membership of the Global Asthma Network Study Group is provided in the Acknowledgements.)

Abstract

Patients with asthma need uninterrupted supplies of affordable, quality-assured essential medicines. However, access in many low- and middle-income countries (LMICs) is limited. The World Health Organization (WHO) Non-Communicable Disease (NCD) Global Action Plan 2013–2020 sets an 80% target for essential NCD medicines’ availability. Poor access is partly due to medicines not being included on the national Essential Medicines Lists (EML) and/or National Reimbursement Lists (NRL) which guide the provision of free/subsidised medicines. We aimed to determine how many countries have essential asthma medicines on their EML and NRL, which essential asthma medicines, and whether surveys might monitor progress. A cross-sectional survey in 2013–2015 of Global Asthma Network principal investigators generated 111/120 (93%) responses—41 high-income countries and territories (HICs); 70 LMICs. Patients in HICs with NRL are best served (91% HICs included ICS (inhaled corticosteroids) and salbutamol). Patients in the 24 (34%) LMICs with no NRL and the 14 (30%) LMICs with an NRL, however no ICS are likely to have very poor access to affordable, quality-assured ICS. Many LMICs do not have essential asthma medicines on their EML or NRL. Technical guidance and advocacy for policy change is required. Improving access to these medicines will improve the health system’s capacity to address NCDs.

Suggested Citation

  • Karen Bissell & Philippa Ellwood & Eamon Ellwood & Chen-Yuan Chiang & Guy B. Marks & Asma El Sony & Innes Asher & Nils Billo & Christophe Perrin & the Global Asthma Network Study Group, 2019. "Essential Medicines at the National Level: The Global Asthma Network’s Essential Asthma Medicines Survey 2014," IJERPH, MDPI, vol. 16(4), pages 1-15, February.
    • Handle: RePEc:gam:jijerp:v:16:y:2019:i:4:p:605-:d:207248
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/16/4/605/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/16/4/605/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Zaheer-Ud-Din Babar & Charon Lessing & Cécile Mace & Karen Bissell, 2013. "The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-Income Countries," PharmacoEconomics, Springer, vol. 31(11), pages 1063-1082, November.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Felix Khuluza & Lutz Heide, 2017. "Availability and affordability of antimalarial and antibiotic medicines in Malawi," PLOS ONE, Public Library of Science, vol. 12(4), pages 1-15, April.
    2. Boniface Ayanbekongshie Ushie & David Betelwhobel Ugal & Justin Agorye Ingwu, 2016. "Overdependence on For-Profit Pharmacies: A Descriptive Survey of User Evaluation of Medicines Availability in Public Hospitals in Selected Nigerian States," PLOS ONE, Public Library of Science, vol. 11(11), pages 1-13, November.
    3. May Chien Chin & Sheamini Sivasampu & Ee Ming Khoo, 2017. "Prescription of oral short-acting beta 2-agonist for asthma in non-resource poor settings: A national study in Malaysia," PLOS ONE, Public Library of Science, vol. 12(6), pages 1-12, June.
    4. Yan Song & Ying Bian & Tianmin Zhen, 2018. "Making medicines more accessible in China: An empirical study investigating the early progress of essential medicine system," PLOS ONE, Public Library of Science, vol. 13(8), pages 1-13, August.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:16:y:2019:i:4:p:605-:d:207248. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.